Resibufogenin Targets the ATP1A1 Signaling Cascade to Induce G2/M Phase Arrest and Inhibit Invasion in Glioma

Resibufogenin (RB) is a major active ingredient in the traditional Chinese medicine Chansu and has garnered considerable attention for its efficacy in the treatment of cancer. However, the anticancer effects and underlying mechanisms of RB on glioblastoma (GBM) remain unknown. Here, we found that RB...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xun, Yao, Zhong, Xue, Zhiyi, Wang, Shuai, Liu, Xuemeng, Hu, Yaotian, Zhang, Yan, Wang, Jian, Li, Xingang, Chen, Anjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152115/
https://www.ncbi.nlm.nih.gov/pubmed/35656311
http://dx.doi.org/10.3389/fphar.2022.855626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152115/
https://www.ncbi.nlm.nih.gov/pubmed/35656311
http://dx.doi.org/10.3389/fphar.2022.855626

Ejemplares similares